Antimicrobial resistance - Judicious use is the key

Canadian Journal of Infectious Diseases

Volumn 15, Issue 5, 2004, Pages 249-251

  Conly, John M ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; COTRIMOXAZOLE; INORGANIC SALT; METICILLIN; PENICILLIN G; PLANT EXTRACT; SULFONAMIDE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIUM; CARBUNCLE; COST; DRUG SAFETY; EDITORIAL; ENTEROCOCCUS; HUMAN; INFECTION; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROORGANISM; NONHUMAN; PNEUMONIA; SEPTICEMIA; SIDE EFFECT; SOYBEAN; WOUND INFECTION;

EID: 9344262295     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/680349     Document Type: Editorial

References (30)

1. Weinstein L. General considerations. In: Goodman LS, Gilman A, eds. The Pharmacological Basis of Therapeutics. New York: Macmillan, 1970:1154.
2. Fleming A. Nobel Lecture, December 11, 1945. Nobel e-Museum. 〈http://www.nobel.se/medicine/laureates/1945/fleming-lecture.html〉 (Version current at September 14, 2004).
3. Moberg CL. René Dubos: A harbinger of microbial resistance to antibiotics. Microb Drug Resist 1996;2:287-97
4. Gold HS, Moellering RC. Antimicrobial-drug resistance. N Engl J Med 1996;335:1445-53.
5. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994;264:375-82.
6. Levy S. Antibiotic resistance: An ecological imbalance. Ciba Found Symp 1997;207:1-14.
7. World Health Organization. Overcoming antimicrobial resistance. 〈http://www.who.int/infectious-disease-report/2000/index.html〉 (Version current at September 14, 2004).
8. Casellas JM, Blanco MG, Pinto ME. The sleeping giant. Antimicrobial resistance. Infect Dis Clin North Am 1994;8:29-44.
9. Panlilio AL, Culver DG, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975 to 1991. Infect Control Hosp Epidemiol 1992;13:582-6.
10. Simor AE, Augustin A, Ng J, Betschel S, McArthur M. Control of MRSA in a long-term care facility. Infect Control Hosp Epidemiol 1994;15:69-70.
11. Vortel JJ, Bell A, Farley JD, Shaw C, Guite A, Harper B. Methicillin-resistant Staphylococcus aureus (MRSA) in a British Columbia hospital - 1990. Can Dis Wkly Rep 1991;17:71-2.
12. Simor AE, Ofner-Agostini M, Bryce E, et al. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ 2001;165:21-6.
13. Kibsey PC, Willey B, Low DE, Cain D, Boychuk LR, Heule M. Vancomycin-resistant Enterococcus faecium: First Canadian isolate. 61st Conjoint Meeting of Infectious Diseases. Vancouver, November 8 to 10, 1993:K5. (Abst)
14. Conly JM, Ofner ME, Paton S, et al. The emerging epidemiology of vancomycin-resistant enterococci in Canada 1993-1998: Results from the Canadian Nosocomial Infection Surveillance Program (CNISP) Passive Reporting Network. Can J Infect Dis 2001;12:364-70.
15. Johnston L, Ofner-Agostini M, Gravel D, et al, for the Canadian Hospital Epidemiology Committee and the Canadian Nosocomial Infection Surveillance Program. Vancomycin-resistant enterococci in Canadian health care facilities: 5 years of prospective surveillance (1998-2003). Infectious Diseases Society of America, Boston, September 30 to October 3, 2004.
16. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States 1989-1993. MMWR Morb Mortal Wkly Rep 1993;42:597-9.
17. Martone WJ. Spread of vancomycin-resistant enterococci: Why did it happen in the United States? Infect Control Hosp Epidemiol 1998;19:539-45.
18. Mulvey MR, Bryce E, Boyd D, Ofner-Agostini M, et al. Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp in Canadian hospitals. Antimicrob Agents Chemother 2004;48:1204-14.
19. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001;32(Suppl 2):S94-103.
20. Wang E, Kellner JD, Arnold S. Antibiotic-resistant Streptococcus pneumoniae. Implications for medical practice. Can Fam Physician 1998;44:1881-8.
21. Adam D. Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother 2002;50(Suppl 1):1-5.
22. Simor AE, Louie M, Low DE. Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumonias. Canadian Bacterial Surveillance Network. Antimicrob Agents Chemother 1996;40:2190-3.
23. Zhanel GG, Palatnick L, Nichol KA, Bellyou T, Low DE, Hoban DJ. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: Results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother 2003;47:1867-74.
24. Powis J, McGeer A, Green K, et al. In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002. Antimicrob Agents Chemother 2004;48:3305-11
25. McIsaac WJ, Mazzulli T, Moineddin R, Raboud J, Rodd S. Uropathogen antibiotic resistance in adult women presenting to family physicians with uncomplicated cystitis. Can J Infect Dis Med Microbiol 2004;15:266-70.
26. Zhanel GG, Karlowsky JA, Harding GKM, et al. A Canadian national surveillance study of urinary tract isolates from outpatients: Comparison of the activities of trimethoprimsulfamethoxazole, ampicillin, mecillinam, nitrofurantoin and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother 2000;44:1089-92.
27. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996;275:234-40.
28. McIsaac W, To T. Antibiotics for lower respiratory tract infections. Still too frequently prescribed? Can Fam Physician 2004;50:569-75.
29. Conly J. Antimicrobial resistance in Canada. CMAJ 2002;167:885-91.
30. Canadian Committee on Antibiotic Resistance. National Policy Conference on Antibiotic Resistance, October 5 to 7, 2002: Summary of proceedings. CCDR 2003;29:153-7. 〈http://www.hc-sc.gc.ca/pphb-dgspsp/publicat/ccdr-rmtc/ 03pdf/cdr2918.pdf〉 (Version current at October 1, 2004).